Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
2646 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2025-03-03 (investors.com)
S&P 500: Own 15 Stocks Morningstar Calls 'Wealth Destroyers?' | Investor's Business Daily
The S&P 500 can generate massive wealth. But stocks can decimate portfolio, too. Morningstar blames 15 stocks for billions in losses.
Read more
2025-02-20 (boursier.com)
Biogen Idec gagne 0,29%
(Boursier.com) - The Biogen IDEC action ended up slightly on the New York Stock Exchange. An increase of 0.29%, the action which ended at $ 137.080 against $ 136.680 at the end, the day before.
Read more
2025-02-13 (asianetnews.com)
Biogen Stock Slides To Fresh 12-Year Lows As Profit Outlook Misses, But Retail Snaps Up The Dip-
The company's breakthrough Alzheimer's drug, Leqembi, generated $87 million in Q4 sales, well ahead of the $67 million analysts expected.
Read more
2025-02-12 (schaeffersresearch.com)
Hot Inflation Data Pressures Stock Futures Lower - Schaeffer's Investment Research
Stock futures are sharply lower this morning, as investors unpack hotter-than-expected inflation data for January
Read more
2025-02-02 (investor-sms.de)
Biogen share: Admission of Alzheimer's medication on the tilt -
Kulmbach (www.aktienscheck.de) - Biogen -shares analysis of "The Shareholder": Michel Doepke from the investor magazine "The shareholder" takes the Biogen Inc. share in a recent stock analysis (ISIN: US09062x1037, WKN: 789617, ticker-S ...
Read more
2025-01-29 (nasdaq.com)
March 2026 Options Now Available For Biogen (BIIB) |
Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 416 days until expiration the newly trading contracts rep
Read more
2025-01-28 (saludnews.net)
Sage rejects biogen purchase offer and seeks strategic alternatives | News health
Biogen, which currently has 10.2% participation in Sage, had proposed to buy the remaining shares at a price of $ 7.22 per share. Sage Therapeutics has rejected an acquisition offer by biogen valued at 469 million dollars, arguing that the proposal "significantly underestimate" the value of the company and not ...
Read more
2025-01-16 (marketbeat.com)
Czech National Bank Acquires 1,923 Shares of Biogen Inc. (NASDAQ:BIIB)
Czech National Bank boosted its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 6.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,595 shares of the biotechnology company's stock after acquiring
Read more
2025-01-16 (investing.com)
Biogen stock touches 52-week low at $144.96 amid challenges By
Biogen stock touches 52-week low at $144.96 amid challenges
Read more